CBUS vs UTHR · rev $2.7M vs P/E 20, rev $1.56B
Cibus Global LLC (CBUS) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Cibus Global LLC (CBUS) is a biotechnology company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CBUS revenue for 2026-06-30 was $2.7M. Net income was -$43.4M. Revenue was up 59.1% from 2026-03-31 to 2026-06-30. CBUS currently screens at market cap $79.7M.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
CBUS currently screens at market cap $79.7M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the CBUS and UTHR stock pages for the full models.
Not investment advice.